GPC3 and hepatocellular carcinoma: Komor et al. [152] identified a GPC3 peptide vaccine, which induces peptide-reactive cytotoxic T lymphocytes (CTLs), and showed that CTLs significantly inhibit the growth of human HCC xenografts in NOD/SCID mice.